PML patient
Aug 05, 2022
New Approved PML Treatment Options – A Long-awaited Hope for PML Patients
Progressive multifocal leukoencephalopathy is a severe, progressive, and lethal demyelinating disease that presents in immunocompromised states. It is a rare indication, with just over 1.5K PML diagnosed incident cases in the United States, per DelveInsight analysis. It occurs in the setting of predisposing immunos...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
